FDA Inspection 1171766 — General Hospital Corporation (The)

General Hospital Corporation (The) — FEI 1270485

The FDA completed an inspection of General Hospital Corporation (The) on Jun 13, 2022 in Boston, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 13, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Boston, MA (United States)

Citations

IDCFRDescription
1776321 CFR 212.20(d)Determination need for investigation
1776421 CFR 212.20(e)Written QA procedures established, followed
1781221 CFR 212.50Adequate controls (general)
2137321 CFR 212.30(b)Equipment procedures
2137621 CFR 212.30(a)Orderly handling, prevention of mix-ups, prevention of contamination